US Patent 10647963 Enhanced adoptive cell therapy
Patent 10647963 was granted and assigned to TILT Biotherapeutics on May, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10647963 Enhanced adoptive cell therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
